Test Price
2,800 AED✅ Home Collection Available
ARSB Gene Mucopolysaccharidosis Type 6 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ARSB لداء عديد السكاريد المخاطي النوع السادس (MPS VI) بتقنية التسلسل الجيني الكامل (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
الملخص التنفيذي
دقة تشخيصية تصل إلى 99.9% باستخدام تقنية التسلسل الجيني الكامل (NGS) عبر مختبر معتمد من ISO 9001:2015 (الشهادة INT/EGQ/2509DA/3139). خدمة سحب منزلي فاخرة بنظام سلسلة تبريد معتمد وموظفي فصد متنقلين VIP | استشارة هاتفية سريرية بعد الفحص لتفسير النتائج | تحقق من تغطية التأمين عبر واتساب على الرقم +971 54 548 8731. جميع الخدمات وفق المرسوم الاتحادي رقم 41 لسنة 2024 المادة 87 وقانون حماية الطفل 2026 وقانون حماية البيانات الشخصية الإماراتي.
Executive Summary: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS processing (Cert: INT/EGQ/2509DA/3139). Premium cold-chain home collection with VIP mobile phlebotomy included. Post-test telephonic clinical guidance for result interpretation. Direct insurance billing verification through WhatsApp +971 54 548 8731. Fully compliant with UAE Federal Decree-Law No. 41 of 2024 (Art. 87), CDS Law 2026 (Minors), and UAE PDPL.
Overview
The ARSB Gene Genetic Test screens for pathogenic variants in the arylsulfatase B gene, confirming Mucopolysaccharidosis Type 6 (Maroteaux‑Lamy syndrome). This high‑coverage next‑generation sequencing assay delivers definitive molecular diagnosis for metabolic disorder evaluation. يقوم التحليل بفحص شامل لجين ARSB لتأكيد تشخيص النوع السادس من داء عديد السكاريد المخاطي بدقة فائقة.
| Aspect | Our Test (NGS Full Gene Sequencing) | Closest Alternative (Targeted Genotyping) |
|---|---|---|
| Precision | Single‑nucleotide resolution across entire ARSB coding region | Limited to pre‑selected common mutations only |
| Method | Next‑Generation Sequencing (Illumina® platform) with 100× mean coverage | Sanger sequencing of selected exons or PCR‑based arrays |
| Speed | Results in 3–4 Weeks (from sample receipt) | 6–8 Weeks |
رؤية الطبيب وبروتوكول السلامة
Note from Dr. PRABHAKAR REDDY (DHA License: 61713011):
Every MPS VI story is unique—this genetic test does not replace a careful clinical evaluation. I see families searching for answers, and while NGS is exceptionally powerful, results must be correlated with enzymatic assays and clinical symptoms. Your journey deserves a compassionate team; we are here to guide you through each finding, no matter the outcome.
⚠️ Medication Warning: Do not discontinue any prescribed medication or enzyme replacement therapy without explicit direction from your treating physician. Genetic results inform long‑term management—they must never prompt immediate changes to current care without clinical oversight.
Safety Exclusion Criteria & ER Red Flags
- Exclusion: Minors (<18 years) must have guardian consent per UAE CDS Law 2026; inability to provide guardianship documentation or refusal of genetic counselling session.
- Exclusion: Individuals unable to provide a venous blood, extracted DNA, or FTA card sample (finger‑prick drop acceptable under supervision).
- Red Flags: Acute neurological deterioration, severe respiratory distress, or acute pain – seek emergency medical care immediately; this test is designed for elective, planned diagnostic investigation, not for crisis intervention.
- Red Flags: Experience of severe psychological distress upon considering genetic results – contact your genetic counsellor or call emergency services; our team provides immediate support pathways.
الأسئلة الشائعة والتوجيه السريري
Q1: What exactly does the ARSB NGS test detect, and how reliable is it for MPS VI diagnosis?
Answer: This test sequences the entire coding region of the ARSB gene with >99.9% analytical sensitivity, identifying both known pathogenic mutations and novel variants that cause Mucopolysaccharidosis type 6. Combined with clinical and enzymatic correlation, it provides a definitive molecular confirmation, fulfilling DHA and international guidelines. يكشف الاختبار طفرات جين ARSB بدقة تتجاوز 99.9%، ويُعدّ تأكيدًا جزيئيًا نهائيًا عند توافق النتائج مع التقييم السريري والإنزيمي.
Q2: How is the sample collected and what preparation is required before the test?
Answer: A blood, extracted DNA, or a single drop of blood on an FTA card is collected by our VIP home phlebotomy team, which operates 8 AM–11 PM daily with a certified cold‑chain logistics system that preserves DNA integrity. No fasting is needed; however, a mandatory genetic counselling session to draw a detailed pedigree chart is required prior to testing. تُسحب العينة منزليًا (دم كامل، DNA مستخلص، أو قطرة دم على بطاقة FTA) دون الحاجة لصيام، مع جلسة استشارة وراثية إلزامية لرسم شجرة العائلة.
Q3: How long until I receive results and what does a positive finding mean for my family?
Answer: Results are reported within 3 to 4 weeks, accompanied by a post‑ tele‑consultation to explain variant pathogenicity and inheritance patterns (autosomal recessive). A positive ARSB mutation confirms MPS VI and enables carrier testing for family members, guiding reproductive options and early treatment initiation. تظهر النتائج خلال 3-4 أسابيع وتتضمن استشارة هاتفية توضح نمط الوراثة المتنحية وتُساعد في فحص أفراد العائلة والتخطيط الإنجابي.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians